IDH2 and glioma: The MS assay optimized in our laboratory is able to reveal LOH at 1p/19q chromosome arms and the presence of hotspot mutations in IDH1, IDH2, and TERT. It was optimized and validated by the analysis of 50 glioma samples, as detailed below.